Terms: = Head and neck cancer AND IKZF1, LyF-1, 10320, ENSG00000185811, Q13422, Hs_54452, hIk-1, ZNFN1A1, IKAROS AND Prognosis
3 results:
1. Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.
Wang J; Tian Y; Zhu G; Li Z; Wu Z; Wei G; Zhuang L; Li Z; Chen X; Zhang X; Zheng J; Cai G
Int Immunopharmacol; 2021 Aug; 97():107817. PubMed ID: 34091115
[TBL] [Abstract] [Full Text] [Related]
2. Laryngeal Squamous Cell Carcinoma: Potential Molecular Mechanism and Prognostic Signature Based on Immune-Related Genes.
Mo BY; Li GS; Huang SN; Wei ZX; Su YS; Dai WB; Ruan L
Med Sci Monit; 2020 Dec; 26():e928185. PubMed ID: 33361747
[TBL] [Abstract] [Full Text] [Related]
3. Integrative genomic analyses on IL28RA, the common receptor of interferon-lambda1, -lambda2 and -lambda3.
Yang L; Luo Y; Wei J; He S
Int J Mol Med; 2010 May; 25(5):807-12. PubMed ID: 20372826
[TBL] [Abstract] [Full Text] [Related]
